<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40450302</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1868-7083</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Clinical epigenetics</Title><ISOAbbreviation>Clin Epigenetics</ISOAbbreviation></Journal><ArticleTitle>Epigenetic age acceleration mediates the association between low-grade systemic inflammation and cardiovascular diseases: insight from the NHANES 1999-2002.</ArticleTitle><Pagination><StartPage>89</StartPage><MedlinePgn>89</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13148-025-01895-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Currently, with the global aging of the population, inflammation, recognized as a hallmark in age-related diseases, has been studied and linked to cardiovascular diseases (CVD). However, limited evidence on whether inflammation modifies epigenetic aging and affects CVD risk.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study included 404 CVD patients and 1941 non-CVD individuals from the 1999-2002 National Health and Nutrition Examination Survey cross-sectional data. Low-grade systemic inflammation was assessed using C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and systemic inflammation response index (SIRI). Epigenetic age accelerations (EAAs) were calculated as the residuals between chronological and epigenetic ages: Horvath age acceleration (AgeAccel), AgeAccelHannum, and AgeAccelPheno. Weighted linear and logistic regression analyzed the associations between exposures and outcomes, with mediating effects assessed using the Sobel test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After adjusting confoundings, the log-transformed NLR and SIRI were positively associated with CVD risk, and the odds ratio (OR) ranges from 1.260 to 1.354 (all P&#x2009;&lt;&#x2009;0.05). Furthermore, the ln-transformed CRP was positively associated with AgeAccelHannum and AgeAccelPheno, and the coefficient (&#x3b2;) ranges from 0.505 to 1.304 (all P&#x2009;&lt;&#x2009;0.05); the ln-transformed NLR and SIRI were positively associated with all three EAAs, and the &#x3b2; ranges from 0.392 to 2.212 (all P&#x2009;&lt;&#x2009;0.005). Additionally, 1-unit increase in AgeAccelHannum and AgeAccelPheno was associated with 2.8% (OR: 1.028,&#xa0;95% CI 1.007-1.049, P&#x2009;=&#x2009;0.011) and 3.5% (OR: 1.035,&#xa0;95% CI 1.014-1.056, P&#x2009;=&#x2009;0.002) increase in CVD risk, respectively. After adjusting confoundings, mediation analysis showed that AgeAccelHannum mediates 10.44% (P&#x2009;=&#x2009;0.046) of the association between NLR and CVD risk; and AgeAccelPheno mediates 24.03% (P&#x2009;=&#x2009;0.009) and 18.16% (P&#x2009;=&#x2009;0.015) of the NLR-CVD and SIRI-CVD risk associations, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results demonstrate that EAAs mediate the association between systemic inflammation and CVD risk, highlighting the potential of a multi-target approach to inflammation and epigenetic modifications for personalized management to reduce CVD risk.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Xiaolang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhong</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Yingnan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, University Engineering Research Center of Digital Medicine and Healthcare, Guangxi Medical University, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Lancheng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Huijiao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yongmei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Jinfan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, 530021, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huabei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of General Practice, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, 530021, Guangxi, China. whbgxmu@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Haiying</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, 530021, Guangxi, China. zhanghaiying@gxmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, 530021, Guangxi, China. zhanghaiying@gxmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, School of Medicine, Guangxi University of Science and Technology, Liuzhou, 545006, Guangxi, China. zhanghaiying@gxmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82160158</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2017GXNSFDA198032</GrantID><Agency>Natural Science Foundation of Guangxi Province</Agency><Country/></Grant><Grant><GrantID>[2024] No. 047</GrantID><Agency>Guangxi Medical Products Administration</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Epigenetics</MedlineTA><NlmUniqueID>101516977</NlmUniqueID><ISSNLinking>1868-7075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Epigenetic age acceleration</Keyword><Keyword MajorTopicYN="N">Low-grade systemic inflammation</Keyword><Keyword MajorTopicYN="N">Mediation</Keyword><Keyword MajorTopicYN="N">NHANES</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: This study only used publicly accessible databases, in which informed consent was obtained and ethical reviews were completed separately in each study. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40450302</ArticleId><ArticleId IdType="doi">10.1186/s13148-025-01895-z</ArticleId><ArticleId IdType="pii">10.1186/s13148-025-01895-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">27523477</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehw334</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindstrom M, DeCleene N, Dorsey H, Fuster V, Johnson CO, LeGrand KE, Mensah GA, Razo C, Stark B, Varieur Turco J, et al. Global Burden of cardiovascular diseases and risks collaboration, 1990&#x2013;2021. J Am Coll Cardiol. 2022;80(25):2372&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">36517116</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2022.11.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Mensah GA, Fuster V, Murray CJL, Roth GA. Global burden of cardiovascular diseases and risks, 1990&#x2013;2022. J Am Coll Cardiol. 2023;82(25):2350&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">38092509</ArticleId><ArticleId IdType="pmc">7615984</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2023.11.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, Li H, Chin YH, Kong G, Anand VV, et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prevent Cardiol. 2024. https://doi.org/10.1093/eurjpc/zwae281 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjpc/zwae281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong Z, Xie Y, Li K, Yuan R, Zhang L. The global burden and risk factors of cardiovascular diseases in adolescent and young adults, 1990&#x2013;2019. BMC Public Health. 2024;24(1):1017.</Citation><ArticleIdList><ArticleId IdType="pubmed">38609901</ArticleId><ArticleId IdType="pmc">11010320</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-18445-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Henein MY, Vancheri S, Longo G, Vancheri F. The role of inflammation in cardiovascular disease. Int J Mol Sci. 2022;23(21):12906.</Citation><ArticleIdList><ArticleId IdType="pubmed">36361701</ArticleId><ArticleId IdType="pmc">9658900</ArticleId><ArticleId IdType="doi">10.3390/ijms232112906</ArticleId></ArticleIdList></Reference><Reference><Citation>Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA. Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors. Diab Metab Res Rev. 2022;38(3):e3502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3502</ArticleId></ArticleIdList></Reference><Reference><Citation>Goswami SK, Ranjan P, Dutta RK, Verma SK. Management of inflammation in cardiovascular diseases. Pharmacol Res. 2021;173:105912.</Citation><ArticleIdList><ArticleId IdType="pubmed">34562603</ArticleId><ArticleId IdType="pmc">8541927</ArticleId><ArticleId IdType="doi">10.1016/j.phrs.2021.105912</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, He D, Yu J, Chen S, Wu Q, Cheng Z, Wei Q, Xu Y, Zhu Y, Wu S. Dynamic status of sii and siri alters the risk of cardiovascular diseases: evidence from kailuan cohort study. J Inflamm Res. 2022;15:5945&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">36274831</ArticleId><ArticleId IdType="pmc">9584782</ArticleId><ArticleId IdType="doi">10.2147/JIR.S378309</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu L, Xia Z, Qing B, Wang W, Chen H, Wang J, Chen Y, Gai Z, Hu R, Yuan Y. Systemic Inflammatory Response Index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001&#x2013;2018). Front Immunol. 2024;15:1338025.</Citation><ArticleIdList><ArticleId IdType="pubmed">38558798</ArticleId><ArticleId IdType="pmc">10978803</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1338025</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zhang W, Liu Z, Ou J, Sun Y, Zhang L, Ji G (2024) Association between systemic inflammation markers and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease. Nutrition, metabolism, and cardiovascular diseases. NMCD.103781</Citation></Reference><Reference><Citation>Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet. 2008;371(9623):1547&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18321568</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(08)60313-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Brant LCC, Ribeiro AH, Pinto-Filho MM, Kornej J, Preis SR, Fetterman JL, Eromosele OB, Magnani JW, Murabito JM, Larson MG, et al. Association between electrocardiographic age and cardiovascular events in community settings: the Framingham heart study. Circ Cardiovasc Qual Outcomes. 2023;16(7):e009821.</Citation><ArticleIdList><ArticleId IdType="pubmed">37381910</ArticleId><ArticleId IdType="pmc">10524985</ArticleId><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.122.009821</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.</Citation><ArticleIdList><ArticleId IdType="pubmed">24138928</ArticleId><ArticleId IdType="pmc">4015143</ArticleId><ArticleId IdType="doi">10.1186/gb-2013-14-10-r115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, Klotzle B, Bibikova M, Fan JB, Gao Y, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49(2):359&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">23177740</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2012.10.016</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Cabo F, Fuster V, Silla-Castro JC, Gonz&#xe1;lez G, Lorenzo-Vivas E, Alvarez R, Callejas S, Bengur&#xed;a A, Gil E, N&#xfa;&#xf1;ez E, et al. Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study. Eur Heart J. 2023;44(29):2698&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">37339167</ArticleId><ArticleId IdType="pmc">10393076</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehad361</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan R, Fu Q, Sun Y, Li Q. Epigenetic clock: a promising biomarker and practical tool in aging. Ageing Res Rev. 2022;81:101743.</Citation><ArticleIdList><ArticleId IdType="pubmed">36206857</ArticleId><ArticleId IdType="doi">10.1016/j.arr.2022.101743</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, Hou L, Baccarelli AA, Stewart JD, Li Y, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018;10(4):573&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">29676998</ArticleId><ArticleId IdType="pmc">5940111</ArticleId><ArticleId IdType="doi">10.18632/aging.101414</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, Mohammadi-Shemirani P, Fornage M, Kornej J, Brody JA, et al. Epigenetic age and the risk of incident atrial fibrillation. Circulation. 2021;144(24):1899&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pubmed">34587750</ArticleId><ArticleId IdType="pmc">8671333</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.056456</ArticleId></ArticleIdList></Reference><Reference><Citation>Si J, Chen L, Yu C, Guo Y, Sun D, Pang Y, Millwood IY, Walters RG, Yang L, Chen Y, et al. Healthy lifestyle, DNA methylation age acceleration, and incident risk of coronary heart disease. Clin Epigen. 2023;15(1):52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-023-01464-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Chen W, Razavi AC, Shi M, Pan Y, Li C, Argos M, Layden BT, Daviglus ML, He J, et al. Associations of epigenetic age acceleration with CVD risks across the lifespan: the bogalusa heart study. JACC Basic Transl Sci. 2024;9(5):577&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">38984046</ArticleId><ArticleId IdType="pmc">11228118</ArticleId><ArticleId IdType="doi">10.1016/j.jacbts.2024.01.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabacik S, Lowe D, Fransen L, Leonard M, Ang SL, Whiteman C, Corsi S, Cohen H, Felton S, Bali R, et al. The relationship between epigenetic age and the hallmarks of aging in human cells. Nature aging. 2022;2(6):484&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">37034474</ArticleId><ArticleId IdType="pmc">10077971</ArticleId><ArticleId IdType="doi">10.1038/s43587-022-00220-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev. 2020;159:133&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">32628989</ArticleId><ArticleId IdType="doi">10.1016/j.addr.2020.06.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolia V, Cavallaro RA, L&#xf3;pez-Gonz&#xe1;lez I, Maccarrone M, Scarpa S, Ferrer I, Fuso A. DNA methylation profiles of selected pro-inflammatory cytokines in alzheimer disease. J Neuropathol Exp Neurol. 2017;76(1):27&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">28053004</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberale L, Montecucco F, Tardif JC, Libby P, Camici GG. Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease. Eur Heart J. 2020;41(31):2974&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">32006431</ArticleId><ArticleId IdType="pmc">7453832</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehz961</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberale L, Badimon L, Montecucco F, L&#xfc;scher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol. 2022;79(8):837&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">35210039</ArticleId><ArticleId IdType="pmc">8881676</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2021.12.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryuzaki S, Kondo Y, Nakano M, Nakano M, Kajiyama T, Ito R, Yoshino Y, Komai Y, Takanashi Y, Kobayashi Y. Novel predictor of thrombosis after left atrial appendage closure -neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR). Eur Heart J. 2024. https://doi.org/10.1093/eurheartj/ehae666.619 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae666.619</ArticleId></ArticleIdList></Reference><Reference><Citation>National health and nutrition examination survey homepage [Internet]. Available from: https://www.cdc.gov/nchs/nhanes/index.html 2025 [cited 2025 Apr. 28]</Citation></Reference><Reference><Citation>National Health and Nutrition Examination Survey 1999&#x2013;2000 and 2001-2002 DNA Methylation Array and Epigenetic Biomarkers Data Documentation [Internet]. Available from: https://wwwn.cdc.gov/Nchs/data/nhanes/dnam/NHANES%20DNAm%20Epigenetic%20Biomarkers%20Data%20Documentation.pdf . 2025 [cited 2025 Apr. 28].</Citation></Reference><Reference><Citation>Kresovich JK, Harmon QE, Xu Z, Nichols HB, Sandler DP, Taylor JA. Reproduction, DNA methylation and biological age. Human Reprod. 2019;34(10):1965&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/dez149</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Li X, Wang K, Iyer G, Sakowski SA, Zhao L, Teener S, Bakulski KM, Dou JF, Traynor BJ, et al. Epigenetic age acceleration is associated with occupational exposures, sex, and survival in amyotrophic lateral sclerosis. EBioMedicine. 2024;109:105383.</Citation><ArticleIdList><ArticleId IdType="pubmed">39369616</ArticleId><ArticleId IdType="pmc">11491892</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2024.105383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye L, Zhang C, Duan Q, Shao Y, Zhou J. Association of magnesium depletion score with cardiovascular disease and its association with longitudinal mortality in patients with cardiovascular disease. J Am Heart Assoc. 2023;12(18):e030077.</Citation><ArticleIdList><ArticleId IdType="pubmed">37681518</ArticleId><ArticleId IdType="pmc">10547298</ArticleId><ArticleId IdType="doi">10.1161/JAHA.123.030077</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Liu B, Sun Y, Snetselaar LG, Wallace RB, Bao W. Trends in adherence to the physical activity guidelines for americans for aerobic activity and time spent on sedentary behavior among US Adults, 2007 to 2016. JAMA Netw Open. 2019;2(7):e197597.</Citation><ArticleIdList><ArticleId IdType="pubmed">31348504</ArticleId><ArticleId IdType="pmc">6661709</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.7597</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi B, Veeranki SP, Zhao M, Ma C, Yan Y, Mi J. Relationship of alcohol consumption to all-cause, cardiovascular, and cancer-related mortality in U.S. adults. J Am College Cardiol. 2017;70(8):913&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.06.054</ArticleId></ArticleIdList></Reference><Reference><Citation>Dustin D, Kowalski C, Salesses M, McDowell A, Kris-Etherton PM, Belury M, Johnson LK, Conrad Z. Carbohydrate intakes below recommendations with a high intake of fat are associated with higher prevalence of metabolic syndrome. J Acad Nutr Diet. 2023;123(7):1022-1032.e1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">36841355</ArticleId><ArticleId IdType="doi">10.1016/j.jand.2023.02.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir CB, Jan A (2025) BMI classification percentile and cut off points. In: StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Arif Jan declares no relevant financial relationships with ineligible companies. StatPearls Publishing. Copyright &#xa9; 2025, StatPearls Publishing LLC</Citation></Reference><Reference><Citation>Dhingra R, He F, Al-Shear L, Saunders EFH, Chinchilli VM, Yanosky JD, Liao D. Cardiovascular disease burden is associated with worsened depression symptoms in the US general population. J Affecti disorders. 2023;323:866&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.12.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor HA Jr, Coady SA, Levy D, Walker ER, Vasan RS, Liu J, Akylbekova EL, Garrison RJ, Fox C. Relationships of BMI to cardiovascular risk factors differ by ethnicity. Obesity. 2010;18(8):1638&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">19927137</ArticleId><ArticleId IdType="doi">10.1038/oby.2009.407</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X, Lu Y, Chen PY, Wong CH. The mediating effect of depression on the relationship between osteoarthritis and cardiovascular disease mortality: a cohort study. J Affect Disord. 2023;341:329&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">37643679</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2023.08.108</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang Y, Li R, Ni B, Chen R, Huang Y, Cheng R, Li P, Li H, Peng Y, et al. Low-grade systemic inflammation links heavy metal exposures to mortality: a multi-metal inflammatory index approach. Sci Total Environ. 2024;947:174537.</Citation><ArticleIdList><ArticleId IdType="pubmed">38977088</ArticleId><ArticleId IdType="doi">10.1016/j.scitotenv.2024.174537</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda JF, Ram&#xed;rez CM, Mittelbrunn M. Inflammaging, a targetable pathway for preventing cardiovascular diseases. Cardiovasc Res. 2024. https://doi.org/10.1093/cvr/cvae240 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvae240</ArticleId><ArticleId IdType="pubmed">39530590</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonopoulos AS, Angelopoulos A, Papanikolaou P, Simantiris S, Oikonomou EK, Vamvakaris K, Koumpoura A, Farmaki M, Trivella M, Vlachopoulos C, et al. Biomarkers of vascular inflammation for cardiovascular risk prognostication: a meta-analysis. JACC Cardiovasc Imaging. 2022;15(3):460&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">34801448</ArticleId><ArticleId IdType="doi">10.1016/j.jcmg.2021.09.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Lin C, Cai X, Hu S, Lv F, Yang W, Zhu X, Ji L. Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: a systematic review and meta-analysis of randomized controlled trials. Atherosclerosis. 2023;379:117181.</Citation><ArticleIdList><ArticleId IdType="pubmed">37527612</ArticleId><ArticleId IdType="doi">10.1016/j.atherosclerosis.2023.06.972</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C, Beitler JJ, Peng G, Levine ME, Conneely KN, Zhao H, Felger JC, Wommack EC, Chico CE, Jeon S, et al. Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: a longitudinal study. Cancer. 2021;127(18):3361&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">34027995</ArticleId><ArticleId IdType="doi">10.1002/cncr.33641</ArticleId></ArticleIdList></Reference><Reference><Citation>Wielscher M, Mandaviya PR, Kuehnel B, Joehanes R, Mustafa R, Robinson O, Zhang Y, Bodinier B, Walton E, Mishra PP, et al. DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases. Nat Commun. 2022;13(1):2408.</Citation><ArticleIdList><ArticleId IdType="pubmed">35504910</ArticleId><ArticleId IdType="pmc">9065016</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-29792-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Switzer CH (2023) Non-canonical nitric oxide signalling and DNA methylation: Inflammation induced epigenetic alterations and potential drug targets. Br J Pharmacol</Citation></Reference><Reference><Citation>Meng W, Fenton CG, Johnsen KM, Taman H, Florholmen J, Paulssen RH. DNA methylation fine-tunes pro-and anti-inflammatory signalling pathways in inactive ulcerative colitis tissue biopsies. Sci Rep. 2024;14(1):6789.</Citation><ArticleIdList><ArticleId IdType="pubmed">38514698</ArticleId><ArticleId IdType="pmc">10957912</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-57440-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Du T, Shen X, Zhan R. Association of mixed polycyclic aromatic hydrocarbons exposure with cardiovascular disease and the mediating role of inflammatory indices in US adults. Environ Health Prev Med. 2024;29:70.</Citation><ArticleIdList><ArticleId IdType="pubmed">39662918</ArticleId><ArticleId IdType="pmc">11652969</ArticleId><ArticleId IdType="doi">10.1265/ehpm.24-00091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Sun M, Guo Y, Yan S, Li X, Wang X, Hu W, Yang Y, Li J, Li B. The role of dietary inflammatory index on the association between sleep quality and long-term cardiovascular risk: a mediation analysis based on NHANES (2005&#x2013;2008). Nat Sci Sleep. 2022;14:483&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">35330783</ArticleId><ArticleId IdType="pmc">8939873</ArticleId><ArticleId IdType="doi">10.2147/NSS.S357848</ArticleId></ArticleIdList></Reference><Reference><Citation>Skoblow HF, Proulx CM. C-Reactive protein, subjective aging, and incident cardiovascular disease: a mediation model. J Gerontol B Psychol Sci Soc Sci. 2022;77(9):1654&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">35279030</ArticleId><ArticleId IdType="pmc">9434473</ArticleId><ArticleId IdType="doi">10.1093/geronb/gbac051</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>